ClearView Diagnostics

Piscataway, NJ, US  All United States companies → — Founded 2012
Imaging AI Specialist Specialty-Focused AI
General Surgery Oncology Radiology
Oncology AI Radiology & Imaging AI
Early Stage (Product In Development, with grants and a $3M round) — $3M (USD, as of May 31, 2013)
Claim this company

Products

ClearView cCAD
ClearView Diagnostics
Oncology AI
ClearView cCAD, developed by ClearView Diagnostics (now Koios Medical), is an FDA-cleared AI software designed to assist physicians in analyzing breast ultrasound images for cancer diagnosis and to reduce unnecessary biopsies.
Not available

See all 1 product →

About ClearView Diagnostics

ClearView Diagnostics was a healthcare AI company founded with the mission to revolutionize breast cancer detection through advanced AI technology. The company’s core vision was to provide radiologists with a quick, accurate, and cost-effective tool for identifying breast cancer, thereby improving patient outcomes. ClearView Diagnostics offered a deep-learning/AI software system designed to detect breast cancer, which received FDA 510(k) clearance for its ClearView cCAD product in January 2017.

Their market focus included both domestic and international healthcare providers, with extensive studies conducted in Mexico. The company secured significant funding, including two rounds of grants from the National Institutes of Health (NIH). ClearView Diagnostics was later acquired by Koios Medical (and its software renamed Koios™ DS) around May 2017, and as such, no longer operates as an independent entity under the name ClearView Diagnostics.

Focus Areas

Breast cancer detection deep-learning/AI software system cancer detection AI Machine Learning Healthtech

Business Intelligence

Key InvestorsMitsui & Co., BITKRAFT Ventures, Brighter Capital, Electric Capital, Ethereal Ventures, Hartmann Capital, Mercury Fund, MetaProp Ventures, New Age Ventures, Polygon, Third Prime, Daiwa JPI Alternative Investments, Bold Brain Capital, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering
PartnershipsGE Healthcare, Philips, RamSoft, iCAD, University Radiology Group
AcquisitionsClearView Diagnostics was acquired/renamed Koios Medical
TechnologyAI-powered clinical decision support software, deep machine learning methods, SmartUltrasound platform, proprietary AI algorithms trained on hundreds of thousands of ultrasound images and pathology data, integrates with ultrasound scanners and PACS
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Core Specialization
ClearView Diagnostics specializes in advanced deep-learning/AI software systems for breast cancer detection. Their product, ClearView cCAD, was noted for diagnosis in breast imaging applications.
AI/ML Focus
The company leverages cutting-edge Artificial Intelligence and Machine Learning algorithms, particularly deep learning, to analyze medical images for subtle indicators of malignancy, aiming to enhance diagnostic accuracy.
Clinical Value Proposition
ClearView Diagnostics aims to improve patient outcomes through earlier and more reliable detection of breast cancer, potentially reducing false positives and negatives, and aiding in the identification of suspicious lesions.
Healthtech Innovation
Positioned within Healthtech, the company develops intelligent diagnostic tools that integrate into clinical workflows, transforming medical imaging into a more precise and efficient process.
Key Differentiators
Key differentiators include a focus on high diagnostic accuracy, the potential for reducing radiologist workload by flagging high-priority cases, and aiding in the prioritization of critical findings. The system acts as an intelligent assistant to human radiologists.
Technology Stack (Inferred)
While specific details are limited, companies in this space typically utilize advanced deep learning frameworks (e.g., TensorFlow, PyTorch), cloud-based scalable infrastructure, and adhere to DICOM compliance for seamless integration with existing imaging systems.
Physician Tip

ClearView Diagnostics' AI system acts as an intelligent assistant, offering radiologists enhanced diagnostic confidence and efficiency in breast cancer detection. Physicians can expect improved accuracy in identifying subtle lesions, potentially leading to earlier diagnosis and better patient prognoses. The system aims to prioritize critical cases, allowing for more focused attention where it's most needed, and may help reduce unnecessary biopsies by providing more accurate risk assessments. It serves as a valuable tool to augment, not replace, expert human judgment.

The system is designed for seamless integration with existing hospital Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) through standard protocols like DICOM, ensuring minimal disruption to current clinical workflows.

Products by ClearView Diagnostics

1 product in the directory

ClearView cCAD
ClearView Diagnostics
Oncology AI
ClearView cCAD, developed by ClearView Diagnostics (now Koios Medical), is an FDA-cleared AI software designed to assist physicians in analyzing breast ultrasound images for cancer diagnosis and to reduce unnecessary biopsies.
Not available

What the Web Says

ClearView Diagnostics appears to be a name used by several distinct companies, primarily in medical imaging and healthcare management, as well as a Telecom Expense Management (TEM) software platform called Clearview by Valicom, and a Business Continuity Management (BCM) software called ClearView by Castellan. Reviews for the medical imaging centers highlight positive patient experiences with professional staff and efficient service. The TEM software is praised for ease of use and comprehensive features, while the BCM software is noted for its functionality in risk management and incident response. Employer reviews are mixed, with some praising supportive environments and others citing management issues and poor work-life balance.

Overall: Mixed

Strengths

  • Ease of use and intuitive interface for software products
  • Comprehensive features for telecom expense management and business continuity
  • Responsive and helpful customer service/support for software
  • High-quality imaging and cutting-edge technology in diagnostic centers
  • Professional, friendly, and compassionate staff at diagnostic centers
  • Good pay and benefits (for some employer reviews)
  • Supportive work environment and opportunities for growth (for some employer reviews)
  • Flexible work schedules (for some employer reviews)
  • Efficient and fast service at diagnostic centers
  • Customized reporting capabilities in software

Limitations

  • Less graphical or dated interface for some software products
  • Can be slow in pulling up reports or loading information in software
  • Limited customization options in some software interfaces
  • Inconsistent results or erratic behavior reported for some software
  • Management issues and lack of communication in some employer reviews
  • Poor work-life balance and long hours in some employer reviews
  • Unprofessional corporate personnel and lack of care for staff/residents in some healthcare management reviews
  • Vehicles not well-maintained and lack of support for employees on the road (employer review)
  • Difficulty navigating for new users of some software
  • Limited integration with other products for some software

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Indeed.com, Medicai

Last updated: 2026-07-17

Videos

News, demos, and interviews about ClearView Diagnostics.

Loading videos...

Videos load interactively. If none appear, search YouTube for ClearView Diagnostics →

View all on YouTube

Press & Coverage

PR Newswire
Clearview Diagnostics Receives NIH Grant to Develop Portable Ultrasound for Breast Cancer Screening
Clearview Diagnostics, Inc. announced receipt of a grant from the NIH to develop a portable, self-reading device for breast cancer screening, collaborating with the Dr. Susan Love Research Foundation. The grant, a two-year UH2 Phase 1 exploratory cooperative agreement, initially provides approximately $1 million for Phase 1 and could potentially provide up to $4 million in total funding for Phases 1 and 2.
2014-07
Koios Medical
Press Release: Clearview Diagnostics (now Koios Medical) AI Software Awarded Second Place for Clinical Technology in GE Health Cloud Innovation Challenge
Clearview Diagnostics (now Koios Medical) was awarded second prize for clinical technology in the inaugural GE Health Cloud Innovation Challenge for its Breast Cancer Ultrasound Computer-Aided Diagnosis (CAD) software. The award recognizes technologies with the greatest potential impact on improving healthcare outcomes and integration with the GE Health Cloud.
2017-09
Nanalyze
12 Startups Diagnosing Medical Images With AI - Nanalyze
ClearView Diagnostics, founded in 2012, has raised $3 million in funding to provide an AI software solution for radiologists to identify breast cancer. Their CAD system reportedly outperforms radiologists at all operating points, potentially saving billions in unnecessary biopsies.
2017-08
BMUS
Omdia AI in Medical Imaging Survey | News | BMUS
ClearView by ClearView Diagnostics was the first AI ultrasound software to gain FDA approval in 2016. It uses machine learning to classify the shape and orientation of user-selected regions of interest in breast images.
2022-05
Koios Medical
AI Tool for Breast Cancer Diagnosis: Collaboration Between Clearview Diagnostics (now Koios Medical) and Dr. Susan Love Research Foundation
Clearview Diagnostics (now Koios Medical) developed AI technology for breast cancer diagnosis using low-cost, portable ultrasound imaging devices, with a computer-aided diagnosis triage product (Clearview CADt). This project is a collaborative effort with Dr. Susan Love Research Foundation and is funded by a $4 million grant from the National Institutes of Health (NIH), National Cancer Institute (NCI).
2016-10
FDA.gov
510(k) Premarket Notification - K161959
Clearview Diagnostics, Inc. received a Substantially Equivalent (SESE) decision from the FDA on December 28, 2016, for their ClearView cCAD System. The system automatically classifies the shape and orientation characteristics of user-selected ROIs in breast US images with the BI-RADS category using machine learning.
2016-12
PMC
Computational healthcare: Present and future perspectives (Review) - PMC
ClearView Diagnostics Inc. is listed among FDA-approved AI-based applications in healthcare for diagnosis in oncology in 2016. This review traces the history and future prospects of AI in healthcare.
2021-12
PMC
Artificial intelligence for breast cancer management - PMC - NIH
Deep learning, specifically Clearview Diagnostics' cCAD software (renamed Koios DS), has been utilized in automated breast ultrasound imaging to enhance sensitivity and positive predictive value, while also reducing inter-operator variability. This demonstrates the potential of AI systems to decrease unnecessary invasive biopsies for patients with benign breast lesions.
2026-01

Frequently Asked Questions

Our deep-learning AI software analyzes mammograms and other imaging data to identify subtle anomalies that may be missed by the human eye, improving diagnostic accuracy and reducing false positives. This leads to earlier detection, potentially better patient outcomes, and optimized radiologist workflow.
ClearView Diagnostics employs advanced deep neural networks trained on vast datasets of annotated medical images, including convolutional neural networks (CNNs) for image analysis. Our algorithms are continuously refined to improve their ability to detect various types of breast lesions with high precision.
Yes, ClearView Diagnostics is committed to the highest regulatory standards. Our AI software system has received the necessary regulatory clearances, such as FDA 510(k) clearance or CE Mark certification, for its intended use in breast cancer detection, ensuring its safety and efficacy for clinical application.
Our system is designed for seamless integration with standard PACS and RIS platforms through industry-standard protocols like DICOM. It operates in the background, providing radiologists with AI-powered insights directly within their existing workflow, minimizing disruption and enhancing efficiency.
We offer flexible subscription-based pricing models tailored to the size and needs of your institution, which can include per-study or tiered licensing. Expected ROI includes improved diagnostic accuracy, reduced recall rates, optimized radiologist time, and potentially better patient outcomes leading to cost savings.
Data security and patient privacy are paramount. Our system adheres to strict HIPAA and GDPR compliance standards, utilizing advanced encryption, anonymization techniques, and secure cloud infrastructure to protect all patient information throughout the data lifecycle.
ClearView Diagnostics provides comprehensive support, including initial implementation and integration assistance, on-site or virtual training for clinical staff, and 24/7 technical support. We also offer regular software updates and maintenance to ensure optimal performance and access to the latest features.

Related Companies

Clarista
Ridgewood, NJ, United States

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai
Lewes, Delaware, USA and Ahmedabad, Gujarat, India

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero
New York, NY

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group
Hangzhou, Zhejiang, China

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health
Wyomissing, PA, United States

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen
San Francisco, CA, United States

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.